Novartis Investigative Site

Toulouse, France 31059

0 studies enrolling now · 3 studies all time

What they study most

Chronic Plaque-type Psoriasis, Moderate to Severe Plaque-type Psoriasis, Plaque-type Psoriasis

Studies at this site

• AIN457 Regimen Finding Study in Patients With Moderate to Severe Psoriasis — Completed
• Efficacy and Safety of Subcutaneous Secukinumab (AIN457) for Moderate to Severe Chronic Plaque-type Psoriasis Assessing Different Doses and Dose Regimens — Completed
• Efficacy and Safety of Intravenous and Subcutaneous Secukinumab in Moderate to Severe Chronic Plaque-type Psoriasis — Completed